SEC Form 4 · accession 0001437749-18-010159
Imunon, Inc. · IMNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alberto R Martinez Jr.
Director
Period of report
May 15, 2018
Accepted (ET)
May 16, 2018 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000749647
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Celsion Corporation Common StockF1,F2 | $2.22 | May 15, 2018 | A | 70,000 | A | May 15, 2018 | May 15, 2028 | Celsion Corporation Common Stock | 70,000 | 93,880 | D |
Explanation of responses
- F1Represents the closing stock price on the option grant date (February 12, 2018) which was subject to the approval of the Celsion Corporation 2018 Stock Incentive Plan at the Annual Meeting of Stockholders held on May 15, 2018.
- F2The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.
Remarks
On February 12, 2018, Celsion's Board of Directors approved a stock option award subject to the approval of the Celsion Corporation 2018 Stock Incentive Plan at the Annual Meeting of Stockholders held on May 15, 2018.